Molson Coors: Cheap Below Book, But the Beer Engine Is Still Shrinking

This week Molson Coors (TAP) took the stage at Barclays' 19th Global Consumer Staples Conference to tell investors the company is in "transition" — U.S. momentum improving, premium brands holding up, AI sharpening its marketing, and a growing push beyond beer into cocktails and spirits that will carry it forward. It is a confident, forward-looking story. Then you look at the stock: about $38, down roughly 30% from its high this past year, sitting almost exactly on its 52-week low, trading below the accounting value of its assets, and paying a 5% dividend. The gap between the pitch on stage and the price in the market is where the whole decision lives — and it is wider than it looks.

The "cheap" multiple is doing real work

On the surface, TAP screens like a textbook value name. A market cap under $7 billion. A price-to-book around 0.65 — you are buying the company for about two-thirds of what its balance sheet says it is worth. A forward P/E near 6x, against Anheuser-Busch InBev at 16x and a 1.3% yield. And a trailing P/E that reads as negative.

That last number is a trap for the unwary. It is not that TAP is losing money from its operations. In 2025 it booked a $3.65 billion goodwill impairment — an accounting write-down, not cash leaving the building — that turned a profitable year into a reported net loss of about $2.1 billion. Strip that out and the company earned $5.42 of "underlying" profit per share in 2025. So "cheap" here is partly real (the market has de-rated the stock hard) and partly a byproduct of a one-time charge. Both are worth understanding before you decide the low price is a bargain.

But the cheapness is pricing a business that is still shrinking

The reason the stock fell to its low is not an accounting blip. The underlying beer business is contracting, and so far it shows no clean turn. Full-year 2025 net sales dropped about 5%, and management guides 2026 to be flat at best. The new CEO's own 2026 targets call for underlying profit to fall 15% to 18% and earnings per share to fall 11% to 15%.

The second quarter, reported in early August, made it look worse, not better: net sales down 3.6%, underlying profit per share down 23% (it still beat a low analyst estimate), total volume down 5.4%, and U.S. domestic shipments down 7.3%. The entire U.S. beer industry was down 4.2% that quarter — and TAP is not just a passive victim of a shrinking category. Its own share has slipped too, down roughly half a point in the second half of 2025. Layer on a $40 million second-quarter cost hit from the "Midwest Premium" aluminum surcharge (a full-year headwind the company now expects to top $130 million) and you have the operating reason for the low: the numbers are still pointing down.

The "beyond beer" story is real — and too small to be the savior

This is the part of the conference pitch that deserves the most scrutiny. Management is selling a "Horizon 2030" strategy: lean into premium brands, cut $450 million of costs over three years, and — the intended growth engine — expand beyond beer into ready-to-drink cocktails and spirits.

The proof so far is genuine but modest. Its acquisition of Monaco (Atomic Brands) is "tracking slightly ahead of acquisition expectations", and its Fever-Tree mixology partnership just posted its best U.S. quarter since the collaboration began. But both of those businesses are on track to add just 1% to 2% of net sales each. That is a real, positive trend — and it is a rounding error against a core beer operation whose volume is falling about 5% a year. A stock bought on the hope that a 1-to-2%-of-revenue side business outgrows and reverses a 90%-of-revenue core decline is a stock bought on a narrative, not on earnings. That is the strongest bear fact against the buy.

What "cheap enough" actually requires

So is it cheap, or cheap and falling? The honest read splits the two. On price, TAP has a genuine margin of safety: below book, 6x forward, a 5% yield, roughly $1.1 billion of expected free cash flow this year, net debt around 2.5 times its underlying earnings, and a $2.35 billion share-buyback authorization it has been steadily working through (it has already repurchased 15% of its Class B shares). The cash flow can honor the dividend and fund the buyback; this is not a balance-sheet crisis.

The risk to a buyer is not a collapse. It is that 2027 looks like 2026, and you are compensated with a 5% yield while the multiple stays pinned. The "cheap enough to own" bridge only gets crossed when the operating trend — U.S. volume, U.S. shipments, and that underlying profit line — flattens out and stops accelerating downward. It has not yet, and Q2 suggested the slide is still in progress.

That is why the right posture right now is closer to "too early" than "buy the fear." The valuation has done a lot of the work for you; the business has not yet proven the downside is over. The single thing that would change the call is the next two or three quarters of U.S. volume and shipments: if they stabilize and the beyond-beer line keeps compounding, a name this cheap and this cash-generative becomes hard to ignore. If the beer trend keeps sliding, the 5% yield is your compensation for waiting — not the reason to reach.